NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 283 filers reported holding NEOGENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,900 | -46.0% | 3,000 | -29.4% | 0.03% | -39.2% |
| Q2 2023 | $68,298 | +30.8% | 4,250 | +41.7% | 0.05% | +24.4% |
| Q1 2023 | $52,230 | +76.6% | 3,000 | -6.2% | 0.04% | +86.4% |
| Q4 2022 | $29,568 | +28.6% | 3,200 | +18.5% | 0.02% | +10.0% |
| Q3 2022 | $23,000 | +4.5% | 2,700 | 0.0% | 0.02% | +11.1% |
| Q2 2022 | $22,000 | +46.7% | 2,700 | +125.0% | 0.02% | +80.0% |
| Q1 2022 | $15,000 | -63.4% | 1,200 | 0.0% | 0.01% | -61.5% |
| Q4 2021 | $41,000 | -71.5% | 1,200 | -59.8% | 0.03% | -75.5% |
| Q3 2021 | $144,000 | +15.2% | 2,988 | +8.0% | 0.11% | +15.2% |
| Q2 2021 | $125,000 | +594.4% | 2,767 | +641.8% | 0.09% | +557.1% |
| Q1 2021 | $18,000 | +5.9% | 373 | +18.0% | 0.01% | -6.7% |
| Q4 2020 | $17,000 | -79.5% | 316 | -85.9% | 0.02% | -80.0% |
| Q3 2020 | $83,000 | +1085.7% | 2,249 | +848.9% | 0.08% | +837.5% |
| Q2 2020 | $7,000 | – | 237 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
| Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
| First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
| PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
| EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
| Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
| FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
| OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
| Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |